More biotechs announce share buybacks; Cosette to buy Mayne Pharma

Plus, news about MeiraGTx, Hookipa and Poolbeg Pharma: A pair of $500M share buybacks: Exelixis and Neurocrine Biosciences each laid out plans to buy back half a ...

Related Posts

Pliant shares plummet as Phase 2b lung fibrosis study p...

Feb 10, 2025  0

FDA places two Indian manufacturers on import alerts ov...

Feb 19, 2025  0

Bristol Myers prunes pipeline amid new round of cost cuts

Feb 9, 2025  0

Comments

Name

Email

Comment

Post Comment